Fig. 1From: Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressantEQ-5D-5L individual dimensions – relative risk for problems. AD, antidepressant; CI, confidence interval; EQ-5D-5L, European Quality of Life-5 Dimension-5 Level; ESK, esketamineBack to article page